These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2192234)

  • 41. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
    Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
    Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein.
    O'Connor KC; Appel H; Bregoli L; Call ME; Catz I; Chan JA; Moore NH; Warren KG; Wong SJ; Hafler DA; Wucherpfennig KW
    J Immunol; 2005 Aug; 175(3):1974-82. PubMed ID: 16034142
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intrathecal and extrathecal production of antibrain antibodies in multiple sclerosis.
    Ryberg B
    J Neurol Sci; 1980 Oct; 48(1):1-8. PubMed ID: 7420122
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
    Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immune complexes in sera of MS patients: a new strategy of the analysis of their antigen portion.
    Wiederkehr F; Büeler MR; Fried R; Vonderschmitt DJ
    Schweiz Arch Neurol Psychiatr (1985); 1993; 144(3):210-2. PubMed ID: 7687368
    [No Abstract]   [Full Text] [Related]  

  • 46. [Significance of increased immunoglobulin G levels in the cerebrospinal fluid of patients with multiple sclerosis].
    Out TA; van der Helm HJ
    Ned Tijdschr Geneeskd; 1984 Sep; 128(35):1666-8. PubMed ID: 6483038
    [No Abstract]   [Full Text] [Related]  

  • 47. Schemes to eradicate the multiple sclerosis central nervous system immune reaction.
    Tourtellotte WW; Murthy K; Brandes D; Sajben N; Ma B; Comiso P; Potvin A; Costanza A; Korelitz J
    Neurology; 1976 Jun; 26(6 PT 2):59-61. PubMed ID: 179031
    [No Abstract]   [Full Text] [Related]  

  • 48. Viral antibody activity of oligoclonal and polyclonal immunoglobulins synthesized within the central nervous system in multiple sclerosis.
    Roström B; Link H; Laurenzi MA; Kam-Hansen S; Norrby E; Wahren B
    Ann Neurol; 1981 Jun; 9(6):569-74. PubMed ID: 7259119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The initiation of the autoimmune response in multiple sclerosis.
    Markovic-Plese S; Pinilla C; Martin R
    Clin Neurol Neurosurg; 2004 Jun; 106(3):218-22. PubMed ID: 15177771
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis.
    Fainardi E; Rizzo R; Melchiorri L; Castellazzi M; Paolino E; Tola MR; Granieri E; Baricordi OR
    Mult Scler; 2006 Feb; 12(1):2-12. PubMed ID: 16459714
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MS: a localized immune disease of the central nervous system.
    Calder V; Owen S; Watson C; Feldmann M; Davison A
    Immunol Today; 1989 Mar; 10(3):99-103. PubMed ID: 2472812
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of B cells in multiple sclerosis: rationale for B-cell-targeted therapies.
    Racke MK
    Curr Opin Neurol; 2008 Apr; 21 Suppl 1():S9-S18. PubMed ID: 18388801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum antimyelin factors in experimental allergic encephalomyelitis and multiple sclerosis.
    Seil FJ; Agrawal HC
    Prog Clin Biol Res; 1984; 146():199-206. PubMed ID: 6201891
    [No Abstract]   [Full Text] [Related]  

  • 54. Protective and detrimental immunity: lessons from stiff person syndrome and multiple sclerosis.
    Holmøy T; Skorstad G; Hestvik AL; Alvik KM; Vartdal F
    Acta Neurol Scand Suppl; 2009; (189):22-6. PubMed ID: 19566493
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response.
    Derfuss T; Gürkov R; Then Bergh F; Goebels N; Hartmann M; Barz C; Wilske B; Autenrieth I; Wick M; Hohlfeld R; Meinl E
    Brain; 2001 Jul; 124(Pt 7):1325-35. PubMed ID: 11408328
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Aspects of antiviral immunity in patients with multiple sclerosis].
    Mayer M
    Cas Lek Cesk; 1985 Jul; 124(28):869-71. PubMed ID: 2411404
    [No Abstract]   [Full Text] [Related]  

  • 57. A study of lactoferrin and antibodies against lactoferrin in neurological diseases.
    Penco S; Villaggio B; Mancardi G; Abbruzzese M; Garre C
    Adv Exp Med Biol; 1998; 443():301-4. PubMed ID: 9781373
    [No Abstract]   [Full Text] [Related]  

  • 58. [Current concepts on intrathecal humoral immune response and diagnostic importance of oligoclonal immunoglobulins in multiple sclerosis].
    Makshakov GS; Lapin SV; Evdoshenko EP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(2 Pt 2):14-20. PubMed ID: 27070356
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oligoclonal and polyclonal synthesis of IgG in the central nervous system: an isoelectric focusing study.
    Arata L; Leonardi A
    Clin Immunol Immunopathol; 1988 Apr; 47(1):10-8. PubMed ID: 3349654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HLA, molecular mimicry and multiple sclerosis.
    Liblau R; Gautam AM
    Rev Immunogenet; 2000; 2(1):95-104. PubMed ID: 11324698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.